h.nakamura
Submits third-party assay reports on material purchased directly. Based in Aalborg.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.50%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043175 | Kisspeptin-10 | GL Biochem | GLBI-2608-N8085 | Kestrel | 2026-Q3 | 99.32 | 3.51 | 99.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042302 | GHRP-2 | HJ | HJ-2602-W3148 | PeptideMeter | 2026-Q2 | 99.55 | 1.32 | 104.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043395 | CJC-1295 with DAC | WXT | WXT-2602-F3755 | Nordanalyt | 2026-Q2 | 98.24 | 4.35 | 89.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020903 | Semaglutide | CPC | CPC-2504-G2724 | Medutest | 2025-Q3 | 98.33 | 5.01 | 96.4 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-020362 | Liraglutide | MKM | MKM-2508-P3929 | Janoshik | 2025-Q3 | 98.16 | 7.03 | 101.8 | Supplier-supplied | 0 | PASS |
| AX-2025-018883 | Retatrutide | QSC | QSC-2504-R9199 | Kestrel | 2025-Q3 | 99.67 | 2.36 | 93.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005541 | NAD+ | QST | QST-2402-B8115 | Nordanalyt | 2024-Q3 | 97.56 | 8.60 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004259 | Semaglutide | QYB | QYB-2311-U4777 | Janoshik | 2024-Q2 | 98.66 | 3.84 | 106.0 | Supplier-supplied | 1 | MARGINAL |